DashboardAll companies
Run this on your own research
Healthcare · Healthcare Plans

Centene Corporation

CNCNYSE$70.17−$1.07 (−1.50%)Market closed

Price Chart

Daily

Key facts

Market Cap
$34.65B
P/E
−5.2x
P/B
1.73x
ROE
−28.8%

Centene Corporation

Healthcare · Healthcare Plans · FY 2025

Centene Corporation is a diversified healthcare enterprise providing a comprehensive range of managed care services to government-sponsored healthcare programs. Specializing in serving uninsured and underinsured populations, Centene offers health plans, benefits management, and other related services. It operates through two primary segments: Managed Care and Specialty Services. The Managed Care segment provides health plan coverage to individuals through Medicaid, Medicare Advantage, and the Health Insurance Marketplace, impacting millions of lives across the United States. Meanwhile, the Specialty Services segment enhances healthcare quality and affordability through offerings such as pharmacy solutions, behavioral health, and optometry services. Founded in 1984 and headquartered in St. Louis, Missouri, Centene plays a significant role in the healthcare sector by addressing accessibility and cost challenges, thereby shaping market trends and influencing policy developments. As a major participant in the managed care industry, Centene is crucial for promoting coordinated care and improving health outcomes for vulnerable populations.

CEO
Ms. Sarah M. London
Employees
60,500

Company Statistics

Valuation

P/E
−5.2x
P/B
1.73x
P/S
0.18x
EV/EBITDA
36.3x
P/FCF
8.0x

Margins

Gross
7.1%
EBITDA
0.5%
Operating
−0.2%
Pre-Tax
−3.5%
Net
−3.4%

Returns

ROA
−8.4%
ROE
−28.8%
ROIC
−7.6%

Growth (CAGR)

Rev 3Yr
10.5%
Rev 5Yr
11.9%
Op Inc 3Yr
—
Net Inc 3Yr
—

Financial Health

Cash & Cash Equivalents
$17.89B
Net Debt
$38.80B
Debt/Equity
282.7%
Interest Cov
—

Profile

Revenue
$194.78B
Shares Out
—
Public markets · Korea, US, Japanalpha-lenz.com · Core by Treasurer
Centene Corporation (CNC) Stock Forecast 2026 $70.17 — Price, Financials & Analyst Targets | AlphaLenz